Molnupiravir
EIDD 2801 is an orally bioavailable broad-spectrum antiviral that inhibits SARS-CoV-2 and other multiple endemic, epidemic and bat coronavirus and has the potential for seasonal and pandemic influenza treatment. An isopropylester prodrug of the ribonucleoside analog of EIDD-1931 that exhibits anti-influenza virus and coronaviruses activities.
| Catalog Number | API2349386894 |
| Alternative Name(s) | ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;EIDD-2801(EIDD 2801);EIDD-2801;Tube994;Molnupiravir(MK-4482);Uridine, 4-oxime, 5'-(2-methylpropanoate);β-D-N4 hydroxycytidine-5'-isopropyl ester;MolnupiravirEIDD-2801(API) |
| Research Area | Antivirus APIs |
| Molecular Formula | C13H19N3O7 |
| CAS# | 2349386-89-4 |
| Inchi Key | HTNPEHXGEKVIHG-JFPRWSRANA-N |
| SMILES | O[C@@H]1[C@@H]([C@@H](COC(=O)C(C)C)O[C@H]1N1C=C/C(=N/O)/NC1=O)O |&1:1,2,3,12,r| |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/molnupiravir-item-6031.html |